Artemisinin ameliorates rheumatoid arthritis through modulation of the IL-17/PI3K/AKT signaling pathway: integrated network pharmacology, bioinformatics, and experimental validation

Zongyuan Zhou, Le Wang, Yongzuo Li, Yue Yang, Lingyu Li, Xing Qin, Thomas Efferth, Xiaohua Lu, Zhe Qiang

Open source

DOI: 10.3389/fimmu.2026.1862104
Published: 2026-08-13
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1862104,
  title = {Artemisinin ameliorates rheumatoid arthritis through modulation of the IL-17/PI3K/AKT signaling pathway: integrated network pharmacology, bioinformatics, and experimental validation},
  author = {Zongyuan Zhou and Le Wang and Yongzuo Li and Yue Yang and Lingyu Li and Xing Qin and Thomas Efferth and Xiaohua Lu and Zhe Qiang},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1862104},
  url = {https://doi.org/10.3389/fimmu.2026.1862104}
}

RIS

TY  - JOUR
TI  - Artemisinin ameliorates rheumatoid arthritis through modulation of the IL-17/PI3K/AKT signaling pathway: integrated network pharmacology, bioinformatics, and experimental validation
AU  - Zongyuan Zhou
AU  - Le Wang
AU  - Yongzuo Li
AU  - Yue Yang
AU  - Lingyu Li
AU  - Xing Qin
AU  - Thomas Efferth
AU  - Xiaohua Lu
AU  - Zhe Qiang
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1862104
UR  - https://doi.org/10.3389/fimmu.2026.1862104
ER  -

APA

Zhou, Z., Wang, L., Li, Y., Yang, Y., Li, L., Qin, X., Efferth, T., Lu, X., & Qiang, Z. (2026). Artemisinin ameliorates rheumatoid arthritis through modulation of the IL-17/PI3K/AKT signaling pathway: integrated network pharmacology, bioinformatics, and experimental validation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1862104

Source records

crossref · retrieved 2026-09-27T15:41:53.611Z